间充质干细胞在抗炎治疗中的应用进展

Research advances in application of mesenchymal stem cells in anti-inflammation therapy

  • 摘要: 间充质干细胞(mesenchymal stem cells,MSCs)是一类具有自我更新、多向分化潜能和低免疫原性的干细胞,其可在炎性因子的作用下通过抑制淋巴细胞的增殖分化、调节自然杀伤性细胞活性、阻止树突状细胞的成熟分化和调节固有免疫细胞等多种途径发挥抗炎作用。在不同诱导条件下,它也能够分化为脂肪、骨、软骨等多种组织细胞。多项实验表明,MSCs在治疗类风湿关节炎、多发性硬化、炎症性肠病、急性肺损伤及其他炎性疾病中具有良好的应用前景。

     

    Abstract: Mesenchymal stem cells (MSCs), a subset of totipotent stem cells, have the ability of self-renewing, multiple differentiation potential and low immunogenicity. They play an important role in immunoregulation by inhibiting the proliferation of lymphocytes, influencing the differentiation and maturity of dendritic cells and modulating natural killer cells and other inherent immunity cells' activity. MSCs can be isolated from bone marrow, umbilical cord amniotic membrance, fat aspirate and dental pulp. Under specific stimulus, they can differentiate into osteocytes, adipocyte, and chondrocytes in vitro. Recent studies have demonstrated that MSCs can effectively treat rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, acute lung injury and other inflammatory diseases, which shows a growing promise in the clinical application.

     

/

返回文章
返回